This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment of shigellosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Mild form of the disease is usually self-limiting and no treatment is necessary. However, it is important to maintain fluid balance with clear oral fluids, or in more severe cases intravenous infusion.

  • seek expert microbiology advice
  • antibiotic treatment is not required for all cases of shigellosis
  • cases with prolonged symptoms or complications may require antibiotics
    • commonly used antibiotics include macrolides, fluoroquinolones, aminoglycosides, sulphonamides, trimethoprim, tetracycline, and third-generation cephalosporins (1,2)
    • in the UK, note that the among GBMSM, the proportion of all Shigella spp. isolates that are multi-drug resistant, or XDR (extensively drug resistant) is very high, often exceeding 90% (2)

A review suggests (3):

The severely ill or those at the extremes of life may be given antibiotic treatment

  • preferred therapy – azithromycin, ceftriaxone
  • alternative agents - ciprofloxacin, cefixime (3)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.